August 18, 2010 ·
2 comments
Lynda Scott joined Thought Leader Select as a research manager in the spring of 2010, after serving the company for three years as a researcher. A native of South Africa, Lynda brings a global perspective into the world of medicine, specializing in leading the company’s research on medical centers of excellence all over the world.
Lynda is no stranger to centers of excellence, having worked in clinical departments in radiotherapy and nuclear medicine in some of South Africa’s premier teaching hospitals and clinics. She holds a master of health science in medical radiation sciences from the University of Sydney (Australia).
Lynda has published research findings in the Journal of Nuclear Medicine Technology, as well as presenting her research at Duke University Medical Center.
The Thought Leader Select Blog sat down with Lynda to discuss her industry experience and her professional contribution to Thought Leader Select.
TLS Blog: Good afternoon, Lynda. Why did you join Thought Leader Select?
Lynda Scott: I’ve been involved in medical research, in both a large hospital setting and private practice, and many of my patients were involved in clinical trials. When an opportunity at Thought Leader Select came along, I wanted to remain in the medical field and still really make a difference in the lives of patients. I loved that I could achieve both of ... read more »
TAGS:
clinical trials
Duke University Medical Center
Journal of Nueclear Medicine Technology
key opinion leaders
KOL identification
KOL profiling
KOLs
Lynda Scott
marathons
medical centers of excellence
medical imaging
nuclear medicine
radiation therapy
radiotherapy
research manager
South Africa
thought leader research
Thought Leader Select
thought leaders
ultramarathons
university hospitals
University of Sydney
April 29, 2010 ·
Leave a comment
Neil Mellor joined Thought Leader Select as its principal business development agent for North America in the spring of 2009. Neil spent over 20 years working at the highest levels of the pharmaceutical industry, including a stint as vice president of business development at Spexell Pharma, a Canadian specialty firm. Mellor has also worked as international public relations manager for Pharmacia (now part of Pfizer), as well as multiple roles at Solvay Pharmaceuticals, including senior product manager for Pantoloc®, director of marketing (interim), and associate director of business development.
The Thought Leader Select Blog recently sat down to catch up with Neil Mellor and learn about his background and how he makes his professional contribution to the work of Thought Leader Select.
TLS Blog: Good morning, Neil. Tell us why you joined Thought Leader Select.
Neil Mellor: I recognized the opportunity, especially in the Canadian market, for the KOL services that Thought Leader Select provides. Traditionally, we’d used influence mapping technology up here, and I felt that, while it was good in some ways, ultimately, it was based on data that was too subjective. I knew, first-hand, that there was a real need for objective, validated research data on KOLs that would help pharma companies manage one of the most important parts of their business—the development of new medicines. I just didn’t feel, ... read more »
TAGS:
Canadian Healthcare Licensing Association
influence mapping
key opinion leaders
KOL engagement
KOL identification
KOL profiling
KOL strategy
Neil Mellor
Panteloc
Pfizer
Pharmacia
Solvay
Spexell Pharma
thought leader research
Thought Leader Select